President Trump has often criticized what he considers to be excessively high drug prices, castigating drug companies and accusing them of “getting away with murder.” He was scheduled to give a major speech on April 26 about initiatives intended to lower prescription drug prices, but it has been postponed until today.
Various proposals from the administration for controlling prices have included capping out-of-pocket drug costs for low-income seniors enrolled in Medicare and ensuring that they don't pay for generics; the creation of a five-state pilot project to allow state Medicaid programs to negotiate prices with manufacturers; limiting the growth of certain Medicare drug payments to the rate of inflation; and requiring insurers to pass drug discounts on to patients.
Read Full Article »